{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:06:32Z","timestamp":1778853992172,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["2 017YFE011010 0"],"award-info":[{"award-number":["2 017YFE011010 0"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["8 172204 6"],"award-info":[{"award-number":["8 172204 6"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["8 177372 7"],"award-info":[{"award-number":["8 177372 7"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["8 197331 6"],"award-info":[{"award-number":["8 197331 6"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2 017YFE011010 0"],"award-info":[{"award-number":["2 017YFE011010 0"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8 172204 6"],"award-info":[{"award-number":["8 172204 6"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8 177372 7"],"award-info":[{"award-number":["8 177372 7"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8 197331 6"],"award-info":[{"award-number":["8 197331 6"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111531","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T04:17:23Z","timestamp":1617337043000},"page":"111531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity"],"prefix":"10.1016","volume":"138","author":[{"given":"Ke","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111531_bib1","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111531_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.freeradbiomed.2021.02.047","article-title":"AMP-activated protein kinase: a remarkable contributor to preserve a healthy heart against ROS injury","volume":"166","author":"Marino","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111531_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global,\u00a0regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111531_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ejhf.1351","article-title":"Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges","volume":"21","author":"Marti","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2021.111531_bib5","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111531_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111531_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jep.2016.07.014","article-title":"Study on material base and action mechanism of compound Danshen dripping pills for treatment of atherosclerosis based on modularity analysis","volume":"193","author":"Zhou","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2021.111531_bib8","doi-asserted-by":"crossref","first-page":"37919","DOI":"10.1038\/srep37919","article-title":"Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111531_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3429151","article-title":"The relationship between compound danshen dripping pills with isosorbide mononitrate in the treatment of elderly patients with unstable angina pectoris","volume":"2018","author":"Liang","year":"2018","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111531_bib10","first-page":"1","article-title":"Systematic review of compound danshen dropping pill: a chinese patent medicine for acute myocardial infarction","volume":"2013","author":"Luo","year":"2013","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111531_bib11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/0366-6999.204106","article-title":"Recommendations on the Clinical Use of Compound Danshen Dripping Pills","volume":"130","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.biopha.2021.111531_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/rb\/rby021","article-title":"In situ cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches","volume":"5","author":"Shafiq","year":"2018","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.biopha.2021.111531_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.phrs.2019.04.013","article-title":"LongShengZhi Capsule reduces carrageenan-induced thrombosis by reducing activation of platelets and endothelial cells","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111531_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","volume":"533","author":"Zhao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.111531_bib15","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1161\/01.CIR.0000148368.79202.F1","article-title":"Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104)","volume":"110","author":"Han","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111531_bib16","doi-asserted-by":"crossref","first-page":"23667","DOI":"10.1074\/jbc.M112.350181","article-title":"Peroxisome Proliferator-activated receptor gamma activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression","volume":"287","author":"Duan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111531_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.28747","article-title":"Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway","volume":"64","author":"Hu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.111531_bib18","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/ATVBAHA.118.311546","article-title":"Inhibition of vascular calcification","volume":"38","author":"Liu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111531_bib19","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.7150\/thno.52435","article-title":"ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2021.111531_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104318","article-title":"Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice","volume":"146","author":"Ren","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111531_bib21","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bph.14156","article-title":"Functional interplay between liver X receptor and AMP-activated protein kinase alpha inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy","volume":"175","author":"Ma","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111531_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cvr\/cvr038","article-title":"Modulating fatty acid oxidation in heart failure","volume":"90","author":"Lionetti","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2021.111531_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCHEARTFAILURE.113.000521","article-title":"Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study","volume":"6","author":"Djouss\u00e9","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2021.111531_bib24","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/ijms20071762","article-title":"The cardioprotective signaling activity of activated protein C in heart failure and ischemic heart diseases","volume":"20","author":"Ren","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111531_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnmol.2018.00267","article-title":"Trilobatin protects against oxidative injury in neuronal PC12 Cells through regulating mitochondrial ROS homeostasis mediated by AMPK\/Nrf2\/Sirt3 signaling pathway","volume":"11","author":"Gao","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2021.111531_bib26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.CIR.99.4.578","article-title":"Glucose for the heart","volume":"99","author":"Depre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111531_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4396368","article-title":"The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2021.111531_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2021.111531_bib29","article-title":"Congestive heart failure in COX2 deficient rats","author":"Wan","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.biopha.2021.111531_bib30","first-page":"1868","article-title":"Bone morphogenetic protein-10 induces cardiomyocyte proliferation and improves cardiac function after myocardial infarction","volume":"115","author":"Sun","year":"2014","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.biopha.2021.111531_bib31","doi-asserted-by":"crossref","first-page":"19877","DOI":"10.1074\/jbc.RA119.010943","article-title":"BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways","volume":"294","author":"Qu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111531_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2011.02.008","article-title":"Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional GxG and GxE differences in health and disease","volume":"11","author":"Murphy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111531_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ahj.2005.03.062","article-title":"Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction","volume":"150","author":"Nakatani","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2021.111531_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2217\/imt.12.139","article-title":"Effect of immune modulation therapy on cardiac function and T-bet\/GATA-3 gene expression in aging male patients with chronic cardiac insufficiency","volume":"5","author":"Han","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biopha.2021.111531_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mod.2008.10.001","article-title":"Lack of Gata3 results in conotruncal heart anomalies in mouse","volume":"126","author":"Raid","year":"2009","journal-title":"Mech. Dev."},{"key":"10.1016\/j.biopha.2021.111531_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ahj.2010.05.022","article-title":"Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study","volume":"160","author":"Gopal","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2021.111531_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/15476286.2017.1311456","article-title":"Hypoxia and Hypoglycemia synergistically regulate mRNA stability","volume":"14","author":"Carraway","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2021.111531_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.01.010","article-title":"Curcumin, the golden spice in treating cardiovascular diseases","volume":"38","author":"Li","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2021.111531_bib39","article-title":"Chinese Patent medicine to treat a 32-year-old man with sinus bradycardia and cardiac sinus arrests: a case report","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2021.111531_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eupc.2005.06.012","article-title":"Paradoxical effect of isoprenaline infusion","volume":"7","author":"Brembilla-Perrot","year":"2005","journal-title":"Europace"},{"key":"10.1016\/j.biopha.2021.111531_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4149\/gpb_2012_015","article-title":"Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol","volume":"31","author":"Nichtova","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.biopha.2021.111531_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1242\/dmm.005017","article-title":"Heart failure and mouse models","volume":"3","author":"Breckenridge","year":"2010","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2021.111531_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.biopha.2018.10.013","article-title":"A review of the mechanism of action of Dantonic((R)) for the treatment of chronic stable angina","volume":"109","author":"Liao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111531_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2014.12.112","article-title":"Systematic review and meta-analysis of randomized controlled trials comparing compound danshen dripping pills and isosorbide dinitrate in treating angina pectoris","volume":"182","author":"Yao","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111531_bib45","first-page":"24","article-title":"Multicenter investigation of Compound Danshen Dripping Pills on short-term clinical events in patient with ST elevation myocardial infarction undergoing primary PCI,(MICD-STEMIPCI)","volume":"19","author":"Li","year":"2011","journal-title":"Chin. J. Interv. Cardiol."},{"key":"10.1016\/j.biopha.2021.111531_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11306-019-1577-3","article-title":"Compound danshen dripping pills normalize a reprogrammed metabolism of myocardial ischemia rats to interpret its time-dependent efficacy in clinic trials: a metabolomic study","volume":"15","author":"Aa","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.biopha.2021.111531_bib47","first-page":"123","article-title":"The effects of compound danshen dripping pills and human umbilical cord blood mononuclear cell transplant after acute myocardial infarction","volume":"12","author":"Jun","year":"2014","journal-title":"Exp. Clin. Transpl."},{"key":"10.1016\/j.biopha.2021.111531_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/13880209.2020.1790619","article-title":"Pre-treatment with compound Danshen dripping pills prevents lipid infusion-induced microvascular dysfunction in mice","volume":"58","author":"Zhang","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2021.111531_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jep.2014.08.023","article-title":"Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia\/reperfusion injury via the Akt-eNOS signaling pathway in rats","volume":"156","author":"Ren-an","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2021.111531_bib50","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fphar.2019.01030","article-title":"Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of sirt1\/FOXO1\/NF-\u03bab signal","volume":"10","author":"Song","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111531_bib51","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1111\/jcmm.13912","article-title":"Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2021.111531_bib52","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fcell.2020.00708","article-title":"Coronin 1B controls endothelial actin dynamics at cell-cell junctions and is required for endothelial network assembly","volume":"8","author":"Werner","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2021.111531_bib53","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2007.01.031","article-title":"Coronin 1B coordinates Arp2\/3 complex and cofilin activities at the leading edge","volume":"128","author":"Cai","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111531_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tcb.2011.04.004","article-title":"Unraveling the enigma: progress towards understanding the coronin family of actin regulators","volume":"21","author":"Chan","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2021.111531_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0167-5273(03)00100-1","article-title":"Genetic variations of matrix metalloproteinase-1 and-3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese","volume":"92","author":"Nojiri","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111531_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/STROKEAHA.110.593798","article-title":"Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study","volume":"42","author":"Sherva","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2021.111531_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4532592","article-title":"Adaptations in protein expression and regulated activity of pyruvate dehydrogenase multienzyme complex in human systolic heart failure","volume":"2019","author":"Sheeran","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2021.111531_bib58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:31:22Z","timestamp":1760099482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":58,"alternative-id":["S0753332221003164"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111531","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111531"}}